stars 1 stars 2 stars 3

The science stack is fragmenting faster than any scientist can manage — thousands of data sources, 700+ models, endless software, agents, omics, lab automation — and it only gets worse. But the value was never in the pieces. It's in bringing them together. The breakthrough isn't in any single model or dataset — it's in fusing them so they produce what none can alone. EMET by BenchSci is a domain-specific AI for drug discovery — a biology-grounded agentic research environment that fuses the fragmented scientific stack into a single system that thinks like a scientist. Grounded in a deep, validated understanding of disease and target biology, and spanning 200 R&D workflows, it brings together data, every frontier, and specialized models, software, and labs in the loop. EMET acts as the conductor of your science: It connects to your internal data, models, software licenses, and cloud, and is tuned by our scientists to your therapeutic areas, compliance, and the way your teams actually work.

BenchSci Questions

The BenchSci annual revenue was $63 million in 2026.

Tom Leung is the Founder and CSO of BenchSci.

160 people are employed at BenchSci.

BenchSci is based in Toronto, Ontario.

The NAICS codes for BenchSci are [511, 51, 5112, 5417, 54, 513, 54171, 541713, 541].

The SIC codes for BenchSci are [73, 737].

Top BenchSci Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users